What are the key aspects of coronary revascularization guidelines for patients with coronary artery disease, including the use of percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG), management of dual antiplatelet therapy with medications such as aspirin, clopidogrel (Plavix), or ticagrelor (Brilinta), and lifestyle modifications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

10-Item Quiz: ACC/AHA/SCAI Coronary Revascularization Guidelines

Question 1: Heart Team Approach

In which clinical scenario is a multidisciplinary Heart Team approach MOST strongly recommended for revascularization decisions?

A) Single-vessel LAD disease in a 55-year-old with normal LV function
B) Diabetic patient with triple-vessel disease considering revascularization options
C) STEMI patient requiring emergent primary PCI
D) Stable angina with 50% mid-RCA stenosis

Correct Answer: B

Explanation: The ACC/AHA/SCAI guidelines give a Class I recommendation for Heart Team approach when the optimal treatment strategy is unclear, with specific emphasis on patients with diabetes and multivessel disease 1. For diabetic patients with triple-vessel disease, the Heart Team must weigh CABG (which is recommended) versus PCI, making this the strongest indication 1.


Question 2: Left Main Disease Revascularization

A 62-year-old with significant left main disease and low-to-medium anatomic complexity (SYNTAX score 18) is being evaluated. Which statement is MOST accurate regarding revascularization?

A) Medical therapy alone is preferred over any revascularization
B) PCI is contraindicated regardless of anatomy
C) Surgical revascularization is indicated to improve survival; PCI is a reasonable alternative
D) The SYNTAX score alone determines the treatment choice

Correct Answer: C

Explanation: For significant left main disease, surgical revascularization is indicated (Class I) to improve survival compared to medical therapy 1. PCI is a reasonable option in selected patients with low-to-medium anatomic complexity when the disease is equally suitable for either approach 1. The 2024 ESC guidelines confirm CABG as the preferred mode given lower rates of spontaneous MI and repeat revascularization 1.


Question 3: Radial Artery Conduit Selection

During CABG planning for a patient requiring bypass of the LAD and a second vessel, which conduit choice for the second most important target vessel provides superior patency and survival?

A) Saphenous vein graft
B) Radial artery
C) Right internal thoracic artery
D) Sequential vein grafting

Correct Answer: B

Explanation: The radial artery is preferred over saphenous vein conduit for bypassing the second most important target vessel after the LAD, with benefits including superior patency, reduced adverse cardiac events, and improved survival 1. This represents a major update in the 2021 ACC/AHA/SCAI guidelines based on contemporary evidence 1.


Question 4: Radial Access for PCI

What is the PRIMARY reason radial artery access is recommended over femoral access for PCI in patients with acute coronary syndrome?

A) Faster procedure time
B) Reduced bleeding and vascular complications; mortality reduction in ACS
C) Lower cost
D) Better angiographic visualization

Correct Answer: B

Explanation: Radial artery access is recommended (Class I) to reduce bleeding and vascular complications compared with femoral approach, and patients with acute coronary syndrome specifically benefit from a reduction in mortality rate 1. The 2018 ESC/EACTS guidelines also give radial access a Class I, Level A recommendation as the standard approach 1.


Question 5: DAPT Duration After PCI for Stable Ischemic Heart Disease

A 58-year-old undergoes PCI with drug-eluting stent for stable angina. After balancing ischemia and bleeding risks, what is a reasonable DAPT strategy according to current guidelines?

A) Lifelong DAPT with aspirin and clopidogrel
B) Aspirin alone immediately after PCI
C) Transition to P2Y12 inhibitor monotherapy after 1-3 months of DAPT
D) DAPT for exactly 12 months, no exceptions

Correct Answer: C

Explanation: A short duration of DAPT after PCI in stable ischemic heart disease is reasonable to reduce bleeding risk, and select patients may safely transition to P2Y12 inhibitor monotherapy and stop aspirin after 1-3 months of DAPT 1. This contrasts with ACS patients who require 12 months of DAPT unless bleeding risk is excessive 1.


Question 6: Non-Culprit Artery Management in STEMI

A 65-year-old presents with anterior STEMI. After successful primary PCI of the LAD, a 90% stenosis is noted in the RCA. The patient is hemodynamically stable with normal renal function. What is the MOST appropriate management of the RCA lesion?

A) Medical therapy only, never intervene on non-culprit arteries
B) Immediate PCI at the time of primary PCI may be considered
C) PCI is harmful and contraindicated
D) Emergent CABG is required

Correct Answer: B

Explanation: Staged PCI of significantly stenosed non-culprit arteries in STEMI is recommended (Class I) to improve outcomes, but PCI at the time of primary PCI may be considered in stable patients with uncomplicated culprit revascularization, low-complexity non-culprit disease, and normal renal function 1. However, non-culprit PCI can be harmful in cardiogenic shock 1.


Question 7: Diabetes and Multivessel Disease

A 70-year-old diabetic patient with triple-vessel CAD (including proximal LAD involvement) and LVEF 55% is being evaluated. Which revascularization strategy is MOST appropriate?

A) PCI is preferred over CABG in all diabetic patients
B) Medical therapy alone is sufficient
C) CABG should be performed; PCI only if poor surgical candidate
D) Either PCI or CABG are equivalent choices

Correct Answer: C

Explanation: Patients with diabetes who have triple-vessel disease should undergo surgical revascularization; PCI may be considered only if they are poor candidates for surgery 1. This recommendation is based on superior long-term outcomes with CABG in diabetic patients with multivessel disease, and decisions should be optimized through Heart Team approach 1.


Question 8: Surgical Risk Assessment

Which scoring system should be calculated for ALL patients being considered for CABG to guide treatment decisions?

A) SYNTAX score
B) Society of Thoracic Surgeons (STS) score
C) GRACE score
D) TIMI risk score

Correct Answer: B

Explanation: Treatment decisions for patients undergoing surgical revascularization should include calculation of the STS score to assess surgical risk 1. In contrast, the SYNTAX score's usefulness is less clear due to interobserver variability and absence of clinical variables 1, 2. The STS score is more important than SYNTAX for CABG candidates 2.


Question 9: DAPT After PCI for NSTE-ACS

A 55-year-old with NSTE-ACS undergoes PCI with drug-eluting stent. What is the recommended duration of DAPT unless bleeding risk is excessive?

A) 1 month
B) 3 months
C) 6 months
D) 12 months

Correct Answer: D

Explanation: In patients with ACS treated with coronary stent implantation, DAPT with a P2Y12 inhibitor on top of aspirin is recommended for 12 months unless there are contraindications such as excessive bleeding risk (e.g., PRECISE-DAPT ≥25) 1. For stable CAD, 6 months is generally recommended, but ACS requires longer duration 1.


Question 10: P2Y12 Inhibitor Selection for NSTE-ACS

A 68-year-old P2Y12-naïve patient with NSTE-ACS is proceeding to PCI. Which P2Y12 inhibitor regimen is recommended as FIRST-LINE therapy?

A) Clopidogrel 600 mg load, 75 mg daily
B) Prasugrel 60 mg load, 10 mg daily
C) Ticlopidine 250 mg twice daily
D) Aspirin monotherapy

Correct Answer: B

Explanation: For P2Y12-naïve NSTE-ACS patients proceeding to PCI, prasugrel (60 mg loading dose, 10 mg daily) is recommended (Class I, Level B) 1. Ticagrelor (180 mg load, 90 mg twice daily) is also Class I regardless of pretreatment strategy 1. Clopidogrel (600 mg load, 75 mg daily) is recommended only when prasugrel or ticagrelor are unavailable or contraindicated 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

SYNTAX Score in Coronary Artery Disease Revascularization

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the methods for revascularization in patients with Coronary Artery Disease (CAD)?
What is the initial management approach for a patient with Coronary Artery Disease (CAD)?
Do I need a stent after Coronary Artery Bypass Grafting (CABG)?
What are the indications for Coronary Artery Bypass Grafting (CABG)?
What is the best approach for a woman in her 60s with three or more blocked arteries?
What are the causes of acute kidney injury due to small vessel and glomerular damage, particularly in patients with pre-existing conditions such as hypertension, diabetes, or a history of kidney disease?
What is the best approach to correct an incorrect benzodiazepine order in an adult patient with a potential history of substance abuse or dependence?
Is carvedilol (a non-selective beta-blocker) superior to propranolol (a non-selective beta-blocker) in patients with decompensated liver disease?
Is an increase in Remicade (infliximab) dosage medically indicated for a patient with rheumatoid arthritis, a history of failed treatments with MTX (methotrexate), Imuran (azathioprine), Prednisone, Enbrel (etanercept), and Rinvoq (upadacitinib), and currently taking Biotin, Hydrolyzed Collagen, Gabapentin, Hydroxychloroquine Sulfate, Imitrex (sumatriptan), Ivermectin 1% External Cream, Magnesium Citrate, Naproxen, Qulipt (quetiapine), and Vitamin D, due to hand pain?
Is clindamycin (antibiotic) harmful to neonates (newborns)?
What is the recommended management for a patient with mumps, considering their vaccination status and medical history?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.